Liver Neoplasms  >>  epirubicin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00058487: Epirubicin and Thalidomide in Treating Patients With Liver Cancer

Completed
2
12
US
epirubicin hydrochloride, thalidomide
Dana-Farber Cancer Institute, National Cancer Institute (NCI)
Liver Cancer
 
01/07
NCT00820053: A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection

Completed
2
450
RoW
epirubicin and lipiodol, transarterial chemoembolization
Eastern Hepatobiliary Surgery Hospital
Hepatocellular Carcinoma
12/09
12/10
SIRTACE, NCT00867750 / 2006-006478-79: SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma

Completed
2
28
Europe
Radioembolisation (SIR-Spheres® microspheres), Transarterial Chemoembolisation
Sirtex Medical
Hepatocellular Carcinoma
06/11
06/11
NCT00021047: Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Completed
1/2
US
capecitabine, carboplatin, epirubicin hydrochloride
National Institutes of Health Clinical Center (CC), National Cancer Institute (NCI)
Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gastric Cancer, Head and Neck Cancer, Liver Cancer, Unspecified Adult Solid Tumor, Protocol Specific
 
06/04
NCT00057980: Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma

Completed
1/2
8
US
celecoxib, epirubicin hydrochloride
Northwestern University, National Cancer Institute (NCI)
Liver Cancer
02/07
02/07

Download Options